Guaifenesin
API
To guarantee the highest purity and therapeutic efficacy, we adhere to strict global standards
To guarantee the highest purity and therapeutic efficacy, we adhere to strict global standards
Guaifenesin is an essential Active Pharmaceutical Ingredient (API) belonging to the Expectorant class. It is the standard compound used to relieve chest congestion and facilitate the removal of mucus from the airways, making it a crucial component in cough, cold, and flu formulations. We supply Guaifenesin in high-purity grades to ensure efficacy and stability across all pharmaceutical preparations.
Cough syrups, and immediate- and extended-release solutions.
Excellent water solubility and compatibility with sweetening and flavoring systems necessary to mask the inherent bitter taste.
Immediate-release tablets and liquid-filled capsules.
Supplied in grades with standardized specifications (e.g., flowability and density) to facilitate compression and high-speed filling processes.
Tablets or granules designed for extended release.
Ideal for formulations requiring a dual or sustained release of the active ingredient over a 12-hour period.
The product conforms to the specified requirements of the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and/or British Pharmacopoeia (BP).
A detailed CoA is issued with every batch, outlining potency, purity profile, and microbiological testing verification.
A comprehensive Drug Master File is available to support registration submissions to regulatory authorities worldwide.
Production takes place in certified facilities that strictly adhere to current Good Manufacturing Practices (cGMP).